This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Harrer, G. Articles by Schulz, V. Search for Related Content PubMed PubMed Citation Articles by Harrer, G. Articles by Schulz, V. Social Bookmarking                         What's this?

Clinical Investigation of the Antidepressant Effectiveness of Hypericum

V. Schulz

To date, 25 controlled therapy studies have investigated the antidepressive effectiveness of hypericum extracts. A total of 1592 treatment cases have been included. The dosage was typically 300 to 900 mg total extract daily; the therapy duration was 2 to 6 weeks. Fifteen studies were performed comparing hypericum extracts with placebo, 10 studies as comparative studies. This paper presents an overview of their results. (J Geriatr Psychiatry Neurol 1994; 7(suppl 1): S6-S8).

Journal of Geriatric Psychiatry and Neurology, Vol. 7, No. 1, S6-S8 (1994)
DOI: 10.1177/089198879400700103


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				Final Report on the Safety Assessment of Hypericum Perforatum Extract and Hypericum Perforatum Oil International Journal of Toxicology, January 1, 2001; 20(2_suppl): 31 - 39. [Abstract] [PDF]

				K.-D. Hansgen, J. Vesper, and M. Ploch Multicenter Double-Blind Study Examining the Antidepressant Effectiveness of the Hypericum Extract LI 160 J Geriatr Psychiatry Neurol, October 1, 1994; 7(1): S15 - S18. [Abstract] [PDF]

				G. Harrer, W.-D. Hubner, and H. Podzuweit Effectiveness and Tolerance of the Hypericum Extract LI 160 Compared to Maprotiline: A Multicenter Double-Blind Study J Geriatr Psychiatry Neurol, October 1, 1994; 7(1): S24 - S28. [Abstract] [PDF]

				B. Martinez, S. Kasper, S. Ruhrmann, and H.-J. Moller Hypericum in the Treatment of Seasonal Affective Disorders J Geriatr Psychiatry Neurol, October 1, 1994; 7(1): S29 - S33. [Abstract] [PDF]

				B. Staffeldt, R. Kerb, J. Brockmoller, M. Ploch, and I. Roots Pharmacokinetics of Hypericin and Pseudohypericin After Oral Intake of the Hypericum Perforatum Extract LI 160 in Healthy Volunteers J Geriatr Psychiatry Neurol, October 1, 1994; 7(1): S47 - S53. [Abstract] [PDF]

				H.-M. Thiede and A. Walper Inhibition of MAO and COMT by Hypericum Extracts and Hypericin J Geriatr Psychiatry Neurol, October 1, 1994; 7(1): S54 - S56. [Abstract] [PDF]

				S. Bladt and H. Wagner Inhibition of MAO by Fractions and Constituents of Hypericum Extract J Geriatr Psychiatry Neurol, October 1, 1994; 7(1): S57 - S59. [Abstract] [PDF]

				H. Wagner and S. Bladt Pharmaceutical Quality of Hypericum Extracts J Geriatr Psychiatry Neurol, October 1, 1994; 7(1): S65 - S68. [Abstract] [PDF]